Average Co-Inventor Count = 6.00
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (11 from 725 patents)
11 patents:
1. 12121572 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
2. 12097248 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
3. 12076380 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
4. 12070491 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
5. 11786583 - Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
6. 11779638 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
7. 11679147 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
8. 11672848 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
9. 11576956 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
10. 11559573 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
11. 11406693 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers